TriMas Co. (NASDAQ:TRS) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. reduced its position in TriMas Co. (NASDAQ:TRS) by 6.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,196 shares of the industrial products company’s stock after selling 3,000 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.10% of TriMas worth $1,013,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Sterling Capital Management LLC boosted its stake in shares of TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company’s stock valued at $32,000 after buying an additional 1,158 shares during the period. MetLife Investment Management LLC raised its position in shares of TriMas by 5.9% during the 4th quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company’s stock worth $610,000 after acquiring an additional 1,378 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of TriMas by 10.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,993 shares of the industrial products company’s stock worth $689,000 after acquiring an additional 2,703 shares in the last quarter. First Eagle Investment Management LLC raised its position in shares of TriMas by 1.8% during the 4th quarter. First Eagle Investment Management LLC now owns 257,506 shares of the industrial products company’s stock worth $6,332,000 after acquiring an additional 4,500 shares in the last quarter. Finally, Quinn Opportunity Partners LLC raised its position in shares of TriMas by 9.9% during the 4th quarter. Quinn Opportunity Partners LLC now owns 62,669 shares of the industrial products company’s stock worth $1,541,000 after acquiring an additional 5,669 shares in the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Trading Down 1.0%

TRS opened at $26.35 on Monday. The firm has a market cap of $1.07 billion, a price-to-earnings ratio of 41.17 and a beta of 0.58. TriMas Co. has a 52 week low of $19.33 and a 52 week high of $28.51. The business’s 50 day moving average is $23.20 and its two-hundred day moving average is $24.00. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60.

TriMas (NASDAQ:TRS) last released its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.43 by $0.03. The company had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share. On average, research analysts predict that TriMas Co. will post 1.69 EPS for the current year.

TriMas Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were paid a $0.04 dividend. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.61%. TriMas’s dividend payout ratio (DPR) is currently 20.78%.

Insider Buying and Selling at TriMas

In related news, CFO Scott A. Mell sold 2,218 shares of TriMas stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the sale, the chief financial officer now directly owns 26,288 shares in the company, valued at $592,531.52. The trade was a 7.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Shawn Sedaghat purchased 72,937 shares of the firm’s stock in a transaction that occurred on Thursday, May 22nd. The stock was acquired at an average price of $26.16 per share, for a total transaction of $1,908,031.92. Following the completion of the purchase, the director now owns 1,883,758 shares of the company’s stock, valued at approximately $49,279,109.28. This represents a 4.03% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 1,770,195 shares of company stock worth $43,736,754. 14.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

TRS has been the topic of several research analyst reports. BWS Financial reissued a “buy” rating and set a $40.00 target price on shares of TriMas in a research report on Wednesday, April 30th. Wall Street Zen raised TriMas from a “hold” rating to a “buy” rating in a research report on Sunday.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.